Sleep apnoea in end-stage renal disease: a short review of mechanisms and potential benefit from its treatment.
Chakravorty
Indranil
I
Department of Respiratory Medicine (L118), East & North Herts NHS Trust, Lister Hospital, Coreys Mill Lane, Stevenage, Herts SG1 4AB, UK. Indranil.chakravorty@nhs.net
Shastry
Manu
M
Farrington
Ken
K
D009320:Atrial Natriuretic Factor / Q000378:metabolism; D003362:Cost-Benefit Analysis; D018450:Disease Progression; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000175:diagnosis*; D016030:Kidney Transplantation; D020097:Natriuretic Peptide, Brain / Q000378:metabolism; D010092:Oximetry; D017286:Polysomnography; D011175:Positive-Pressure Respiration; D020181:Sleep Apnea, Obstructive / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*; D012894:Sleep Stages; D016896:Treatment Outcome
D020097:Natriuretic Peptide, Brain; D009320:Atrial Natriuretic Factor